Kathleen Melbourne Selected Research

Inflammation (Inflammations)

1/2022	Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study.
10/2020	Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIV.
1/2019	Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor.
7/2012	Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen Melbourne Research Topics

Disease

4	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 06/2011
4	Inflammation (Inflammations) 01/2022 - 07/2012
2	Weight Gain 10/2021 - 12/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
1	HIV Infections (HIV Infection) 11/2023
1	Vomiting 01/2022
1	Diarrhea 01/2022
1	Fatigue 01/2022
1	Nausea 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Insulin Resistance 01/2017
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Albuminuria 09/2014
1	Proteinuria 09/2014
1	Chronic Renal Insufficiency 03/2014

Drug/Important Bio-Agent (IBA)

6	Tenofovir (Viread)FDA Link 12/2020 - 06/2011
4	abacavir (Ziagen)FDA Link 11/2023 - 01/2017
4	efavirenz (Sustiva)FDA Link 12/2020 - 06/2011
4	lamivudine drug combination abacavir FDA Link 09/2014 - 06/2011
4	Emtricitabine (Emtriva)FDA Link 09/2014 - 06/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 02/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2014
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2017 - 06/2011
3	Ritonavir (Norvir)FDA Link 01/2017 - 06/2011
2	IntegrasesIBA 01/2022 - 12/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	NucleotidesIBA 12/2020 - 09/2014
2	Reverse Transcriptase InhibitorsIBA 12/2020 - 09/2014
2	RacivirIBA 09/2014 - 07/2012
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Biological FactorsIBA 01/2021
1	bictegravirIBA 12/2020
1	tenofovir alafenamideIBA 12/2020
1	elvitegravirIBA 12/2020
1	dolutegravirIBA 12/2020
1	Rilpivirine (TMC-278)IBA 12/2020
1	CobicistatIBA 12/2020
1	NucleosidesIBA 12/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Zidovudine (Retrovir)FDA LinkGeneric 12/2020
1	InflammasomesIBA 10/2020
1	NLR ProteinsIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	Phosphates (Orthophosphate)IBA 01/2017
1	LipidsIBA 01/2017
1	Thymidine Monophosphate (TMP)IBA 01/2017
1	Phosphorus (Red Phosphorus)IBA 01/2017
1	CreatinineIBA 03/2014
1	Cystatin CIBA 03/2014
1	Cell Adhesion MoleculesIBA 02/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	C-Reactive ProteinIBA 02/2014

Therapy/Procedure

5	Art Therapy 01/2022 - 09/2014
4	Therapeutics 01/2021 - 02/2014